Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

Olga Lourenço; Biljana Cvetkovski; Vicky Kritikos; Rachel House; Sophie Scheire; Elisio M. Costa; João A. Fonseca; Enrica Menditto; Anna Bedbrook; Slawomir Bialek; Vitalis Briedis; Koen Boussery; G. Walter Canonica; Tari Haahtela; Piotr Kuna; Joaquim Mullol; Valentina Orlando; Boleslaw Samolinski; Dana Wallace; Catherine Duggan; Ema Paulino; Goncalo S. Pinto; Lars-Åke Söderlund; Jean Bousquet; Sinthia Bosnic-Anticevich

doi:10.1002/clt2.12183

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

Olga Lourenço, Biljana Cvetkovski, Vicky Kritikos, Rachel House, Sophie Scheire, Elisio M. Costa, João A. Fonseca, Enrica Menditto, Anna Bedbrook, Slawomir Bialek, Vitalis Briedis, Koen Boussery, G. Walter Canonica, Tari Haahtela, Piotr Kuna, Joaquim Mullol, Valentina Orlando, Boleslaw Samolinski, Dana Wallace, Catherine DugganEma Paulino, Goncalo S. Pinto, Lars-Åke Söderlund, Jean Bousquet, Sinthia Bosnic-Anticevich

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

51 Downloads (Pure)

Abstract

Background: Allergic rhinitis (AR) management requires a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians.

Methods: Allergic Rhinitis and its Impact on Asthma (ARIA) first published a reference document on the pharmacist's role in allergic rhinitis management in 2004. Several guidelines were developed over the past 20 years improving the care of allergic rhinitis patients through an evidence-based, integrated care approach.

Results: This ARIA/EAACI/FIP Position Paper is based on the latest ARIA in the Pharmacy guidelines and provides: (a) a structured approach to pharmacists identifying people with AR and/or allergic conjunctivitis as well as those at risk of poor disease control; (b) an evidence-based clinical decision support tool for optimising the management of allergic rhinitis in the community pharmacy; and (c) a framework of referral to the physician.

Conclusion: This document is not intended to be a mandatory standard of care but is provided as a basis for pharmacists and their staff to develop relevant local standards of care for their patients, within their local practice environment. Pharmacy care varies between countries, and the guide should be adapted to the local situation.

Original language	English
Article number	e12183
Pages (from-to)	1-8
Number of pages	8
Journal	Clinical and Translational Allergy
Volume	12
Issue number	10
DOIs	https://doi.org/10.1002/clt2.12183
Publication status	Published - Oct 2022
Externally published	Yes

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

allergic rhinitis
community pharmacy
pharmacist

Access to Document

10.1002/clt2.12183Licence: CC BY

Publisher version (open access)Final published version, 2.58 MBLicence: CC BY

Cite this

Lourenço, O., Cvetkovski, B., Kritikos, V., House, R., Scheire, S., Costa, E. M., Fonseca, J. A., Menditto, E., Bedbrook, A., Bialek, S., Briedis, V., Boussery, K., Canonica, G. W., Haahtela, T., Kuna, P., Mullol, J., Orlando, V., Samolinski, B., Wallace, D., ... Bosnic-Anticevich, S. (2022). Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022. Clinical and Translational Allergy, 12(10), 1-8. Article e12183. https://doi.org/10.1002/clt2.12183

@article{d677ed926a954e01940d5f7c31f4a04f,

title = "Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022",

abstract = "Background: Allergic rhinitis (AR) management requires a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians.Methods: Allergic Rhinitis and its Impact on Asthma (ARIA) first published a reference document on the pharmacist's role in allergic rhinitis management in 2004. Several guidelines were developed over the past 20 years improving the care of allergic rhinitis patients through an evidence-based, integrated care approach.Results: This ARIA/EAACI/FIP Position Paper is based on the latest ARIA in the Pharmacy guidelines and provides: (a) a structured approach to pharmacists identifying people with AR and/or allergic conjunctivitis as well as those at risk of poor disease control; (b) an evidence-based clinical decision support tool for optimising the management of allergic rhinitis in the community pharmacy; and (c) a framework of referral to the physician.Conclusion: This document is not intended to be a mandatory standard of care but is provided as a basis for pharmacists and their staff to develop relevant local standards of care for their patients, within their local practice environment. Pharmacy care varies between countries, and the guide should be adapted to the local situation.",

keywords = "allergic rhinitis, community pharmacy, pharmacist",

author = "Olga Louren{\c c}o and Biljana Cvetkovski and Vicky Kritikos and Rachel House and Sophie Scheire and Costa, {Elisio M.} and Fonseca, {Jo{\~a}o A.} and Enrica Menditto and Anna Bedbrook and Slawomir Bialek and Vitalis Briedis and Koen Boussery and Canonica, {G. Walter} and Tari Haahtela and Piotr Kuna and Joaquim Mullol and Valentina Orlando and Boleslaw Samolinski and Dana Wallace and Catherine Duggan and Ema Paulino and Pinto, {Goncalo S.} and Lars-{\AA}ke S{\"o}derlund and Jean Bousquet and Sinthia Bosnic-Anticevich",

note = "Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2022",

month = oct,

doi = "10.1002/clt2.12183",

language = "English",

volume = "12",

pages = "1--8",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "Springer, Springer Nature",

number = "10",

}

Lourenço, O, Cvetkovski, B, Kritikos, V, House, R, Scheire, S, Costa, EM, Fonseca, JA, Menditto, E, Bedbrook, A, Bialek, S, Briedis, V, Boussery, K, Canonica, GW, Haahtela, T, Kuna, P, Mullol, J, Orlando, V, Samolinski, B, Wallace, D, Duggan, C, Paulino, E, Pinto, GS, Söderlund, L-Å, Bousquet, J & Bosnic-Anticevich, S 2022, 'Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022', Clinical and Translational Allergy, vol. 12, no. 10, e12183, pp. 1-8. https://doi.org/10.1002/clt2.12183

TY - JOUR

T1 - Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

AU - Lourenço, Olga

AU - Cvetkovski, Biljana

AU - Kritikos, Vicky

AU - House, Rachel

AU - Scheire, Sophie

AU - Costa, Elisio M.

AU - Fonseca, João A.

AU - Menditto, Enrica

AU - Bedbrook, Anna

AU - Bialek, Slawomir

AU - Briedis, Vitalis

AU - Boussery, Koen

AU - Canonica, G. Walter

AU - Haahtela, Tari

AU - Kuna, Piotr

AU - Mullol, Joaquim

AU - Orlando, Valentina

AU - Samolinski, Boleslaw

AU - Wallace, Dana

AU - Duggan, Catherine

AU - Paulino, Ema

AU - Pinto, Goncalo S.

AU - Söderlund, Lars-Åke

AU - Bousquet, Jean

AU - Bosnic-Anticevich, Sinthia

N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2022/10

Y1 - 2022/10

N2 - Background: Allergic rhinitis (AR) management requires a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians.Methods: Allergic Rhinitis and its Impact on Asthma (ARIA) first published a reference document on the pharmacist's role in allergic rhinitis management in 2004. Several guidelines were developed over the past 20 years improving the care of allergic rhinitis patients through an evidence-based, integrated care approach.Results: This ARIA/EAACI/FIP Position Paper is based on the latest ARIA in the Pharmacy guidelines and provides: (a) a structured approach to pharmacists identifying people with AR and/or allergic conjunctivitis as well as those at risk of poor disease control; (b) an evidence-based clinical decision support tool for optimising the management of allergic rhinitis in the community pharmacy; and (c) a framework of referral to the physician.Conclusion: This document is not intended to be a mandatory standard of care but is provided as a basis for pharmacists and their staff to develop relevant local standards of care for their patients, within their local practice environment. Pharmacy care varies between countries, and the guide should be adapted to the local situation.

AB - Background: Allergic rhinitis (AR) management requires a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians.Methods: Allergic Rhinitis and its Impact on Asthma (ARIA) first published a reference document on the pharmacist's role in allergic rhinitis management in 2004. Several guidelines were developed over the past 20 years improving the care of allergic rhinitis patients through an evidence-based, integrated care approach.Results: This ARIA/EAACI/FIP Position Paper is based on the latest ARIA in the Pharmacy guidelines and provides: (a) a structured approach to pharmacists identifying people with AR and/or allergic conjunctivitis as well as those at risk of poor disease control; (b) an evidence-based clinical decision support tool for optimising the management of allergic rhinitis in the community pharmacy; and (c) a framework of referral to the physician.Conclusion: This document is not intended to be a mandatory standard of care but is provided as a basis for pharmacists and their staff to develop relevant local standards of care for their patients, within their local practice environment. Pharmacy care varies between countries, and the guide should be adapted to the local situation.

KW - allergic rhinitis

KW - community pharmacy

KW - pharmacist

UR - http://www.scopus.com/inward/record.url?scp=85141201779&partnerID=8YFLogxK

U2 - 10.1002/clt2.12183

DO - 10.1002/clt2.12183

M3 - Article

C2 - 36225265

SN - 2045-7022

VL - 12

SP - 1

EP - 8

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

IS - 10

M1 - e12183

ER -

Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this